nav
Antigen Express
is a platform and product-based company developing proprietary vaccine formulations for large, unmet medical needs.
»
read more about us
8/7/2008
Enrollment of breast and ovarian cancer patients commenced for combination therapy trial to include Generex Biotechnology’s novel immunotherapeutic vaccine
7/9/2008
Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials
6/26/2008
Generex Biotechnology Expands Mayo Clinic Collaboration for Vaccine Studies
© 2004 Antigen Express | One Innovation Drive | Worcester, MA 01605
Phone: (508) 852-8783 | Fax: (508) 852 8653 |
admin@antigenexpress.com
Website designed by
NRG Networks